Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile a...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications & Media Pvt Ltd
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657969/ |
| id |
pubmed-3657969 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-36579692013-06-17 Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes Sekhri, Kavita Saha, Lekha Fast-track Publication Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile acid sequestrant with high capacity for binding bile acids. This drug can offer potential new diabetes treatment along with other drugs. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3657969/ /pubmed/23776789 http://dx.doi.org/10.4103/2229-516X.91157 Text en Copyright: © International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Sekhri, Kavita Saha, Lekha |
| spellingShingle |
Sekhri, Kavita Saha, Lekha Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| author_facet |
Sekhri, Kavita Saha, Lekha |
| author_sort |
Sekhri, Kavita |
| title |
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| title_short |
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| title_full |
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| title_fullStr |
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| title_full_unstemmed |
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes |
| title_sort |
colesevelam hydrochloride: a novel agent in patients with type 2 diabetes |
| description |
Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile acid sequestrant with high capacity for binding bile acids. This drug can offer potential new diabetes treatment along with other drugs. |
| publisher |
Medknow Publications & Media Pvt Ltd |
| publishDate |
2011 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657969/ |
| _version_ |
1611979007998296064 |